Charles Schwab’s RxSight RXST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.8M | Buy |
292,317
+4,994
| +2% | +$64.9K | ﹤0.01% | 2447 |
|
2025
Q1 | $7.25M | Sell |
287,323
-3,431
| -1% | -$86.6K | ﹤0.01% | 2108 |
|
2024
Q4 | $10M | Buy |
290,754
+5,425
| +2% | +$187K | ﹤0.01% | 2013 |
|
2024
Q3 | $14.1M | Buy |
285,329
+62,507
| +28% | +$3.09M | ﹤0.01% | 1878 |
|
2024
Q2 | $13.4M | Buy |
222,822
+29,078
| +15% | +$1.75M | ﹤0.01% | 1892 |
|
2024
Q1 | $9.99M | Buy |
193,744
+3,407
| +2% | +$176K | ﹤0.01% | 1983 |
|
2023
Q4 | $7.67M | Buy |
190,337
+8,003
| +4% | +$323K | ﹤0.01% | 2128 |
|
2023
Q3 | $5.09M | Buy |
182,334
+111,403
| +157% | +$3.11M | ﹤0.01% | 2253 |
|
2023
Q2 | $2.04M | Buy |
70,931
+10,155
| +17% | +$292K | ﹤0.01% | 2544 |
|
2023
Q1 | $1.01M | Buy |
60,776
+7,464
| +14% | +$125K | ﹤0.01% | 2725 |
|
2022
Q4 | $675K | Buy |
53,312
+1,214
| +2% | +$15.4K | ﹤0.01% | 2908 |
|
2022
Q3 | $626K | Buy |
52,098
+3,522
| +7% | +$42.3K | ﹤0.01% | 2937 |
|
2022
Q2 | $684K | Buy |
48,576
+6,106
| +14% | +$86K | ﹤0.01% | 2935 |
|
2022
Q1 | $526K | Buy |
42,470
+19,835
| +88% | +$246K | ﹤0.01% | 3086 |
|
2021
Q4 | $255K | Buy |
22,635
+2,457
| +12% | +$27.7K | ﹤0.01% | 3314 |
|
2021
Q3 | $256K | Buy |
+20,178
| New | +$256K | ﹤0.01% | 3294 |
|